T1	Participants 48 125	after oral microcrystalline and sustained-release preparations in asthmatics.
T2	Participants 207 369	13 asthmatic patients after single and multiple oral dosage of a microcrystalline theophylline tablet (Nuelin) and a sustained-release preparation (Nuelin Retard)
